Kainate binding proteins (KBPs) are highly homologous to ionotropic glutamate receptors; however, no ion channel function has been demonstrated for these proteins. To investigate possible reasons for the apparent lack of ion channel function we transplanted the ion channel domains of five KBPs into glutamate receptors GluR 6 and GluR1. In each case we obtained functional chimeric receptors in which glutamatergic agonists were able to open the KBP-derived ion channel with EC 50 values identical to those of the subunit contributing the ligand binding domain. Maximal current amplitudes were significantly smaller than those of the parent clones, however. We also show that the KBP ion channels are highly permeable for calcium and have certain pharmacological properties that are distinct from all other glutamate receptor (GluR) subunits. Thus, all five known KBPs, in addition to their well characterized functional ligand binding sites, have functional ion permeation pathways. Our data suggest that the lack of ion channel function in wild-type KBPs results from a failure to translate ligand binding into channel opening. We interpret our findings to indicate the requirement for a modulatory protein or an additional subunit serving to alter the structure of the KBP subunit complex such that signal transduction is enabled from the ligand binding site to the intrinsically functional ion pore.
level, indicating that they represent the same gene. The other subunits share between 49.8 and 67.9% sequence identity and thus are derived from different genes. Notably, no KBPs have been discovered in mammals.
There is significant sequence homology (35-40%) between KBPs and other GluRs, particularly the KA receptors. In addition, their transmembrane topology is believed to be identical to that of other GluRs Wo and Oswald, 1994) . The most compelling structural difference between KBPs and other GluRs is their short N-terminal domains (128 -148 amino acids as opposed to ϳ520 for other GluR subunits), which is characteristic for all KBPs (see Fig. 1 ).
To gain insight into the biological role of KBPs we set out to determine whether KBPs could potentially form functional ion channels. We chose a domain transplantation strategy that involved engineering of the ion channel domain of KBPs into functional GluR subunits. This approach was based on recent suggestions that GluRs may be modular proteins made up of building blocks derived from different precursor proteins (Seeburg et al., 1995; Wo and Oswald, 1995; Hollmann, 1996) , a design that should allow domain exchange among subunits.
The domain transplantation experiments described in this study identified the putative ion channel domains of all five KBP genes [KBP(Rp), KBP(Gd), KBP(Ca)␣, KBP(Ca)␤, and KBP(Xl)] as sequences capable of forming functional cation conduction pathways with distinct pharmacological properties. Moreover, these domains are capable of coupling to glutamatergic ligand binding sites, and they permit the flow of calcium ions.
MATERIALS AND METHODS

Mutagenesis.
To allow easy exchange of ion pores between subunits, unique restriction sites were introduced into both donor and acceptor subunits by PCR-based mutagenesis. Homologous positions within each sequence were chosen to engineer an EcoRI site downstream of the pore region at amino acids 211-213 (RII) in K BP(Rp) (the cDNA clone was kindly provided by Drs. K . Wada and R. Wenthold, National Institutes of Health) and at the corresponding amino acids in GluR6(Q) (603-605, RIV) and RIV) . Numbering starts with the first codon of the mature protein. Upstream of the pore region an Nru I site was introduced at amino acids 163-165 (FLV) in K BP(Rp), at amino acids 548 -560 (FV I) in GluR6(Q), and at amino acids 537-539 (FLV) in GluR1 (see Fig. 2 ). The sites were chosen such that the entire pore region including both adjacent intracellular loops (L1 and L2) was transplanted. The resulting constructs were named "x-PC S," where "x" stands for the clone modified and "PC S" means "pore cassette sites". Mutagenetic oligonucleotide primers of 21-36 bp length were obtained from Eurogentec (Seraing, Belgium). A fragment containing both newly generated restriction sites was synthesized in a first round of PCR. The purified fragment was extended C -terminally in a second PCR using wild-type DNA as the template and a tailed primer binding downstream of the gene within the vector sequence. The vector used throughout this study was pSGEM, a modified version of pGEM H E in which we replaced the original multiple cloning site by the pBluescript (Stratagene, Heidelberg, Germany) polylinker; f urthermore, two additional sites for template linearization (the eight-cutters PacI and SfiI) were inserted between the existing SphI and NheI sites. The original pGEM H E vector was kindly provided by Emily Liman and the late Peter Hess (Harvard Medical School). In a third round of PCR the secondround fragment was N-terminally extended using primers binding to the T7 promoter of pSGEM and the tail sequence generated in the second round of PCR, respectively, so that only the mutated strand will be amplified.
PCRs were set up as follows: 1 ng of template DNA, 200 mM Tris-HC l, pH 8.8, 100 mM KC l, 100 mM (N H 4 ) 2 SO 4 , 20 mM MgSO 4 , 1% Triton X-100, 1 mg /ml bovine serum albumin, 50 M each dATP, dC TP, dTTP, and dGTP, 100 pmol of each primer, and 2 U Pfu polymerase (Stratagene). PCR conditions were 5 min /95°C for denaturation, 5 min /50°C for annealing, 5 min /72°C for elongation in the first cycle, followed by 28 cycles of 1 min /95°C, 2 min /50°C, and 2.5 min /72°C. The last cycle ended with a 10 min /72°C amplification step.
The final PCR fragments were cut with suitable restriction sites as close as possible to the region to be transplanted and were reinserted into the respective wild-type clones to minimize any PCR-generated sequence. The following cloning cassettes were used for shuttling: EcoRVAccI [nucleotide (nt) for GluR6(Q), BglII-BglII (nt 1810 -2220) for GluR1, and AflIII-Xcm I (nt 455-720) for K BP(Rp). The resulting mutants were designated GluR6(Q)-PC S, GluR1-PC S, and K BP(Rp)-PC S, respectively, and were used as recipient clones of the pore regions to be transplanted. Next, PCR-amplified fragments of the pore domains of GluR6(Q), K BP(Rp), K BP(C a)␣, K BP(C a)␤, K BP(Gd), and K BP(X l) were generated to include the required flanking EcoRI and Nru I sites, using the appropriate mutagenetic primers. These fragments were digested with EcoRI and Nru I and ligated into the appropriate recipient clones, GluR1-PC S, GluR6(Q)-PC S, or K BP(Rp)-PC S, which had been prepared for ligation by digestion with EcoRI and Nru I. The original cDNA clones of the K BPs were used as starting material. C lones of these K BPs were generously provided by Dr. R. Oswald (Cornell University) (K BP(C a)␣ and K BP(C a)␤) and Dr. V. Teichberg (Weizmann Institute) (K BP(Gd)). For the recently cloned K BP(X l) , a cDNA clone was not available to us. We therefore used an 865 bp PCR-generated fragment (nt 241-1105) amplified from Xenopus cDNA that had been reverse-transcribed from total brain mRNA isolated from 10 female Xenopus laevis.
All mutant clones were sequenced across the PCR-generated fragment with the Sequenase 2.0 sequencing kit (United States Biochemicals, Braunschweig, Germany), which uses the dideoxynucleotide chain termination method (Sanger et al., 1977) . Sequence data were analyzed with the University of Wisconsin software package (Devereux et al., 1984) .
cR NA synthesis. Template DNA was linearized with NheI. cRNA was synthesized from 1 g of linearized DNA using an in vitro transcription kit (Stratagene) with a modified protocol that uses 800 M each nucleotide (except GTP, 200 M), 800 M m7 GpppG (Pharmacia, Freiburg, Germany) for capping, and an extended reaction time of 3 hr with T7 polymerase. Trace labeling was performed with [ 32 P]UTP to allow calculation of yields and transcript quality check by agarose gel electrophoresis.
Electrophysiolog ical measurements in Xenopus ooc ytes. Oocytes of stages V-V I were surgically removed from the ovaries of Xenopus laevis anesthetized with 3-aminobenzoic acid ethylester (2.3 gm / l). The oocytes were incubated in calcium-free Barth's solution (see below) containing 815 U/ml (ϭ2.8 mg /ml) collagenase and 2200 U/ml (ϭ0.15 mg /ml) trypsin for 2.75 hr while they were gently shaken to remove the follicular cell layer. Oocytes were washed five to six times in Barth's solution (88 mM NaC l, 1.1 mM KC l, 2.4 mM NaHC O 3 , 0.3 mM C a(NO) 3 , 0.3 mM CaCl 2 , 0.8 mM MgSO 4 , 15 mM H EPES-NaOH, pH 7.6). After selection the oocytes were kept in Barth's solution containing 63 g /ml penicillin, 40 g /ml streptomycin, and 100 g /ml gentamycin; 10 ng (ϭ50 nl) of cRNA was injected into the oocytes using a 10 l Drummond microdispenser. T wo-electrode voltage-clamp recordings were performed with a T urboTec 10CD amplifier (npi, Tamm, Germany) 4 -8 d after cRNA injection by superf usion of the oocyte with glutamatergic agonists (1-300 M) prepared in normal frog Ringer's solution (N FR) (115 mM NaC l, 2.5 mM KC l, 1.5 mM CaCl 2 , 10 mM H EPES-NaOH, pH 7.2). Voltage electrodes were filled with 3 M KC l and had resistances of ϳ4 M⍀; current electrodes were filled with 3 M C sC l and had resistances of ϳ0.5-1.5 M⍀. Oocytes were held at Ϫ70mV. All measurements of clones based on the K A receptor GluR6 were performed after preincubation of the oocyte with 1 mg /ml concanavalin A (ConA) for 8 min. This treatment eliminates desensitization of K A receptors, particularly GluR6 (Egebjerg et al., 1991) . Agonists were applied for 10 sec by superf usion of the oocyte at a flow rate of 10 -14 ml /min. Currentvoltage ( I-V) relationships were determined with a 2 sec voltage ramp and analyzed using the PulseFit 7.62 program (H EK A Electronics, Lambrecht, Germany). To determine the EC 50 values for K A and Glu, 8 -10 different agonist concentrations were applied to the same oocyte, and steady-state values of the evoked currents were measured. Data from each oocyte were fitted separately, and EC 50 values obtained this way from three to five oocytes were averaged. C alcium permeability tests were performed in low or high "C a-Ringer" lacking any other permeable cation. Both 10 mM C a-Ringer (10 mM H EPES, 10 mM CaCl 2 , 105.2 mM N-methyl-D-glucamine, pH 7.2, adjusted with concentrated HC l) and 80 mM C a-Ringer (80 mM CaCl 2 , 10 mM H EPES, pH 7.2, adjusted with N-methyl-D-glucamine) were used.
Gel electrophoresis and immunoblotting. Batches of 12 oocytes were used for membrane preparations 6 -8 d after cRNA injection, following a previously described protocol . For experiments in which only those proteins inserted into the plasma membrane were to be analyzed, membrane preparations were performed after biotinylConA labeling of glycosylated surface proteins and streptavidinSepharose-mediated precipitation of labeled proteins. Briefly, the oocytes were incubated in 10 M biotinyl-ConA (Sigma, Munich, Germany) in N FR for 30 min at room temperature (RT). After five washes for 10 min each in N FR, oocytes were homogenized with a Teflon pestle in 240 l H-buffer (100 mM NaC l, 20 mM Tris-HC l, pH 7.4, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride plus a cocktail of additional proteinase inhibitors: 2.5 g /ml leupeptin, 20 g /ml aprotinin, 2.5 g /ml pepstatin, and 20 g /ml benzamidine hydrochloride) and kept on ice for 15 min. After centrif ugation for 60 sec at 16,000 ϫ g, the supernatants were supplemented with 20 M washed streptavidin -Sepharose beads (Sigma) and incubated for 3 hr at 4°C on a rotator. The streptavidin -Sepharose beads were pelleted by a 60 sec spin and washed three times with H-buffer, and the final pellets were boiled in 40 l /oocyte SDS-PAGE loading buffer (0.8 M ␤-mercaptoethanol, 6% SDS, 20% glycerol, 25 mM Tris-HC l, pH 6.8, 0.1% bromphenol blue).
Samples were run on 20 cm discontinuous SDS-PAGE gels (Laemmli, 1970 ) (5% stacking gel, 7.5% separating gel; running time 2.5 hr at 4°C). Prestained protein markers (Bio-Rad, Munich, Germany) were used to monitor separation on the gel as well as to identif y the position of immunoreactive bands on blots. The gel was blotted (Towbin et al., 1979) onto Hybond ECL nitrocellulose membranes (Amersham, Braunschweig, Germany) at a constant current of 200 mA for 16 hr at 4°C. Filters were blocked for 2 hr at RT with blocking buffer [1ϫ Roti-block (Roth, Karlsruhe, Germany) in 140 mM NaC l, 0.1% Triton X-100, 20 mM Tris-HC l, pH 7.6] and probed overnight at 4°C with affinity-purified rabbit antisera directed against the C termini of GluR6 (peptide sequence TF N DRRL PGK ETM A) (Wenthold et al., 1994) or K BP(Rp) (peptide sequence K SP TSNSCDEV K A). Both antibodies were kindly provided by Dr. Robert Wenthold. Incubations were performed in 0.1ϫ Roti-block, 0.1% Triton X-100, 140 mM NaC l, 20 mM Tris-HC l, pH 7.6. Peroxidase-labeled donkey anti-rabbit IgG (Dianova, Hamburg, Germany) was used as secondary antibody. Immunoreactive bands were visualized by the chemoluminescence method (ECL detection kit, Amersham).
Reagents. Restriction enzymes were purchased from Boehringer Mannheim (Mannheim, Germany), Promega (Mannheim, Germany), and New England Biolabs (Schwalbach, Germany). All nucleotides were from Pharmacia (Freiburg, Germany). Unless noted otherwise, all chemicals were from Sigma.
RESULTS
N-terminal elongation of KBPs
The most obvious structural difference between f unctional members of the GluR family and the nonf unctional K BPs is the short N-terminal domain of the latter (Fig. 1) . To test whether an extended N-terminal domain would render K BPs f unctional, we engineered the N-terminal sequence of the K A receptor GluR6 (comprising amino acids 1-399) onto the K BP from Rana pipiens. Amino acid 22 (a lysine) of wild-type K BP(Rp) was used as the N-terminal point of connection to create the chimera GluR6N-KBP(Rp)C (Fig. 1) . Unfortunately, this chimera was not functional on expression in Xenopus oocytes (data not shown), although the protein was expressed and inserted into the oocyte plasma membrane (see Fig. 4C ). Coexpression of wild-type GluR6(Q) did not enhance expression levels (see Fig. 4C , right lane) and did not produce any alterations of the f unctional properties found for GluR6(Q) alone (data not shown).
Transplantation of KBP ion pores into functional channels
Another domain critically involved in channel f unction is obviously the ligand binding site. This domain, however, has already been well established as a f unctional site on all cloned KBPs through agonist binding experiments with 3 H-K A (Gregor et al., 1989; Wada et al., 1989; Oswald, 1994, Ishimaru et al., 1996) . An equally important domain that has not received nearly as much attention is the ion channel domain itself. If this domain was intrinsically defective or nonf unctional, obviously no ionic currents would be possible even after binding of the proper ligand. We therefore transplanted the putative ion channel domain of K BP(Rp) into f unctional GluR subunits to test the intrinsic f unctionality of the channel domain in the context of proven f unctional subunits. We chose the AM PA receptor GluR1 (45.9% sequence identity at the amino acid level) and the KA receptor subunit GluR6, which is the most closely related subunit (51.5% sequence identity), as donors for the ligand binding site. The excision points of the transplanted ion channel domain from KBP(Rp) and the corresponding insertion points in GluR1 and GluR6 were chosen such that the entire hairpin loop comprising the putative channel-lining segment could be transplanted together with the flanking intracellular loops L1 and L2 as defined in . The transplanted sequence starts at the C-terminal end of transmembrane domain (TMD) A and runs up to the N-terminal end of TMD B. To facilitate ion pore exchange between various receptor subunits, we inserted unique restriction enzyme sites at the starting points and end point of the region to be transplanted. The resulting constructs made from GluR1, GluR6, and KBP(Rp) were named GluR1-PCS, GluR6-PCS, and KBP(Rp)-PCS, respectively (Fig. 2) (also see Materials and Methods). They served as the parent constructs for all ion channel transplantations performed for this study.
Both chimeric constructs, GluR1-PKBP(Rp) and GluR6-PKBP(Rp), gave functional ion channels that could be activated by KA, Glu, and Dom (Fig. 3B,D) . Maximal current amplitudes of GluR1-PKBP(Rp) (6.3 Ϯ 0.4 nA for KA currents; n ϭ 7) and GluR6-PKBP(Rp) (9.03 Ϯ 0.2 nA; n ϭ 39) were rather small compared with those of wild-type GluR1 (3157 Ϯ 711 nA for KA currents; n ϭ 4) and wild-type GluR6 (14550 Ϯ 1892 nA; n ϭ 4), respectively (ϳ1%). They could be reproducibly measured in every oocyte tested, however, provided that current desensitization was minimized by ConA pretreatment of oocytes expressing GluR1-PKBP(Rp) and GluR6-PKBP(Rp) (see Materials and Methods). Additionally, cyclothiazide was coapplied for recordings of GluR1-PKBP(Rp), because this compound specifically blocks desensitization at AMPA receptors (Partin et al., 1993) . Interestingly, despite the pronounced difference between wildtype GluR1 and GluR6 in maximal current amplitudes (the ratio found was 1:ϳ4.6), the two chimeras GluR1-PKBP(Rp) and GluR6-PKBP(Rp) had similar currents (a ratio of 1:ϳ1.4), indicating that the transplanted KBP pore rather than the sequence background of the ligand binding site donor subunit determined the maximal currents.
To test whether the ion channel domains of other KBPs were similarly capable of conducting currents, we engineered the respective domains of KBP(Xl) , KBP(Ca)␣ and KBP(Ca)␤ (Wo and Oswald, 1994) , and KBP(Gd) (Gregor et al., 1989) into GluR6 using the same strategy as described above for KBP(Rp) (for details, see Materials and Methods). All chimeras containing KBP ion channel transplants were expressed at the protein level (Fig. 4 A, panel T ) and were inserted into the plasma membrane (Fig. 4 A, panel P) , and all were functional ( Fig.  3E-H ). GluR6-PKBP(Ca)␣ gave the largest maximal amplitudes (Table 1) , which were in the range of 7% of wild-type GluR6(Q) or 17% of GluR6(Q)-PCS (see Materials and Methods) for both Glu-and KA-evoked currents.
We recorded dose-response curves for KA-and Glu-evoked currents of wild-type GluR6(Q), GluR6(Q)-PCS, and the five chimeras harboring KBP ion pores. The mutant GluR6(Q)-PCS, which carries the engineered sites for ion channel exchange but has the original ion channel domain of GluR6(Q), displays a small (1.7-fold) decrease in Glu affinity compared with wild-type GluR6(Q), whereas the affinity for KA is unchanged (Table 1) . When we analyzed the chimeras we did not find significant differences in the EC 50 values of KA-evoked currents compared with GluR6(Q)-PCS (Fig. 5A,B) , except for GluR6-PKBP(Gd), in which we measured a modest increase in the EC 50 (approximately threefold) ( Table 1) . For Glu-evoked currents we observed no major changes in the EC 50 values (Fig. 5C,D) , with none of the EC 50 deviating by more than a factor of 1.7 from the agonist affinity of GluR6(Q)-PCS (Table 1) . Moreover, those chimeras deviating most from GluR6(Q)-PCS had EC 50 values close to that of wild-type GluR6(Q). Therefore, construction of Figure 1 . Bar graph representation of the structural features of receptor subunits used for ion pore transplantation. K BPs of Rana pipiens (Rp), Gallus domesticus (Gd), Carassius auratus (C a, two subunits, ␣ and ␤), and Xenopus laevis (Xl) are compared with the AM PA receptor GluR1 and the KA receptor GluR6. The chimera GluR6N-K BP(Rp)C is a construct with an N-terminal transplantation between GluR6 (N-terminal part) and KBP(Rp) (C -terminal part); the black circle marks the junction between the two domains. Chimera GluR6-Rp-R6-Rp (bottom bar) is derived from GluR6N-K BP(Rp)C by exchanging the pore domain for that of GluR6(Q). The predicted signal peptides, the three transmembrane domains (TMD A, TMD B, TMD C) and the pore loop domains (the "TMD II" of previous topology models) are indicated by black rectangles.
the chimeras had little effect on the affinities for any of the agonists and thus evidently had no major impact on the ligand binding site.
Channel properties of KBP-GluR6 chimeras
The wild-type GluR6(Q) is characterized by an inwardly rectifying I-V relationship (Egebjerg and Heinemann, 1993) , indicating that outward currents are blocked, presumably by endogenous compounds such as spermine (Bowie and Mayer, 1995) . This block of outward current is determined mainly by the so-called Q/R-site, where either a glutamine (Q) or an arginine (R) residue is found to be located at the presumably most narrow position of the ion channel. The amino acid present at this site is determined by RNA editing (Seeburg, 1996) . We recorded I-V curves of GluR6(Q)-PCS and the five chimeras (Fig. 6 A,B) and determined that all of them had inwardly rectifying I-V relations. Thus, the ion channel of KBPs is susceptible to block of outward current just like the AMPA and KA receptor channels; however, the five chimeras, unlike GluR6(Q) and GluR6(Q)-PCS, did show a small but significant current at positive membrane potentials (Fig.  6 A,B) . This small outward current is not attributable to the activation of calcium-dependent chloride channels, which are endogenous to the oocyte (and which have linear I-V relations), because they persist even in a buffer in which calcium has been replaced by magnesium (Fig. 6C, trace 2) . We speculated that this outward current might be attributable to the fact that in all KBPs cloned so far a leucine is located at the site equivalent to the Q/R editing site of GluR6. We therefore mutated the glutamine at the Q/R-site of GluR6(Q) to a leucine residue and tested this mutant for outward current. As expected, GluR6(Q590L) had an inwardly rectifying I-V and indeed showed small but significant outward currents at positive holding potentials, just like the chimeras (Fig. 6C, trace 4 ). This outward current did not persist in calcium-free NFR (Fig. 6C, trace 3) , however, indicating that the leucine residue at the Q/R-site by itself cannot be the sole determinant of the outward current at positive membrane potentials. To investigate this further we constructed a mutant chimera, GluR6-PKBP(Rp)L583Q, which carries the KBP pore region transplanted into GluR6 but has a glutamine instead of a leucine residue at the Q/R site. This clone is functional, has a rectifying I-V curve, and shows distinct outward currents at positive membrane potentials (Fig. 6C, trace 5) . Thus, determinants of the pore domain of KBPs other than the leucine at the Q/R site are responsible for the slight outward rectification observed on top of a basically inwardly rectifying I-V relation.
The Q/R-site not only determines the rectification properties of GluRs but also has a major impact on calcium permeability. AMPA receptors carrying an edited arginine residue at this position (such as GluR2) are virtually impermeable to calcium, whereas unedited subunits carrying a glutamine residue are calcium permeable (Hume et al., 1991) . Similarly, for KA receptors, "Q" editing variants have a higher calcium permeability than "R" variants, although the latter are not entirely calcium impermeable (Egebjerg and Heinemann, 1993) . Despite the large number of Q/R site mutants reported in the literature, no data are available on a GluR subunit carrying a leucine residue at this position. Consequently, it is difficult to predict whether the presence of a leucine residue at the Q/R site might allow calcium permeability of the ion channel. We therefore tested GluR6(Q)-PCS and GluR6-PKBP(Ca)␣ for calcium permeability using a sodium-and potassium-free modified NFR that contains Ca 2ϩ as the sole cation capable of permeating the ion channel on agonistmediated channel opening (Hollmann et al., 1991) . For GluR6(Q)-PCS we found about the same permeability for Ca 2ϩ as is seen in wild-type GluR6(Q). KA (300 M) in 10 mM Ca-Ringer evoked ϳ60% of the control current seen in NFR, and in 80 mM Ca-Ringer almost as much current can be recorded as in NFR (data not shown). GluR6-PKBP(Ca)␣ was selected for analysis of calcium permeability of KBP pores because this chimera yields the largest currents of the five chimeras. In 10 mM Ca-Ringer, GluR6-PKBP(Ca)␣ gave 5% of the current evoked by 300 M KA in NFR, and in 80 mM Ca-Ringer it yielded 75% of the control current (Fig. 7) . Thus, the KBP(Ca)␣ ion channel domain is capable of fluxing Ca 2ϩ ions to a considerable degree, although not quite to the extent of wild-type GluR6(Q) and GluR6(Q)-PCS. We also tested the pore of KBP(Xl) and found it to flux calcium to a similar degree (data not shown). Thus, the leucine residue at the Q/R site of the pore evidently is compatible with calcium permeating the ion channel. In keeping with these results, we determined that the mutant GluR6(Q590L), which contains a leucine residue at the Q/R site, is also permeable for calcium (data not shown).
The K BP pore domains, just like the pores of GluR6, are not blocked by NMDA receptor channel blockers such as magnesium (Fig. 6C, trace 2) or M K-801. We tested this for GluR6-PK BP(Rp), GluR6-PK BP(C a)␣, and GluR6-PK BP(Gd) (Fig.  8 A) . The K BP pore domains, however, are blocked by zinc, which is a channel blocker at both NMDA and non-NMDA receptors (Westbrook and Mayer, 1987; Rassendren et al., 1990) . We found that 100 M zinc blocked 30% of K A-evoked (100 M) currents at GluR6(Q) as well as GluR6-PK BP(Rp), GluR6-PK BP(C a)␣, and GluR6-PK BP(C a)␤. No block was seen with 1 M zinc (data not shown). Interestingly, the K BP pore domains are not affected by philanthotoxin (PhT x), a wasp toxin (Fig. 8 B) , or by N-(4-hydroxyphenylpropanoyl)-spermine, a synthetic analog of wasp and spider toxins (data not shown). PhT x and spider toxins are known to efficiently block all NMDA receptors and all non-NMDA receptors with rectif ying I-V relations (Blaschke et al., 1993; Herlitze et al., 1993; Washburn and Dingledine, 1996) . We tested GluR6-PK BP(Rp), GluR6-PK BP(C a)␣, GluR6-PK BP(C a)␤, and GluR6-PK BP(Gd) and found no effect of the toxin or its synthetic analog. The toxin block had previously been shown Figure 4 . Western blots demonstrating protein expression of chimeric receptors. A, GluR6(Q) wild-type compared with pore transplantation chimeras of GluR6. B, KBP(Rp) wild-type compared with pore transplantation chimeras of KBP(Rp). C, N-terminus transplantation chimeras between GluR6 and KBP(Rp). Total oocyte proteins (T, 1 oocyte/lane), streptavidin-precipitated biotinyl-ConA-labeled plasma membrane proteins (P, 10 oocytes/lane), and nonbiotinylated controls (PϪ, 10 oocytes/ lane) were separated electrophoretically, blotted, and probed with affinitypurified antibodies generated to the C-terminal peptide of GluR6 ( A) or the C-terminal peptide of KBP(Rp) (B, C). Arrows point to the position of the ϳ120 kDa GluR6 wild-type and pore transplantation mutant proteins in A, to the position of the ϳ48 kDa KBP in B, and to the position of the ϳ118 kDa N-terminal transplantation chimeras between GluR6 and KBP in C. Note that in A an unidentified band cross-reacting with the GluR6 antibody (marked by an asterisk) is present in all control precipitations and even in uninjected oocytes ( panels P, PϪ) . This band is absent from the total oocyte protein ( panel T ) because only a single oocyte was loaded in that case as opposed to 10 oocytes for panels P and PϪ. Note also that specific bands (arrows) are either totally absent (B, C) or only very weak ( A) in precipitation control samples (PϪ) that were not biotinyl-ConA-labeled. This demonstrates that the immunoreactive protein identified in panel P is actually residing in the plasma membrane. KBP(Rp)-PGluR1 in B runs at 4 a slightly larger molecular weight than expected. This erratic running behavior is not attributable to a sequence problem in the construct but likely reflects a conformational peculiarity of this particular construct.
to be determined by the amino acid located at the Q / R / N site, with "Q" and "N" versions being blocked and "R" versions not being blocked. Our data suggested that a leucine residue might also unexpectedly prevent channel block, althoug it does not carry the positive charge of an arginine residue. To verif y this we tested the mutant GluR6(Q590L) for PhT x block and indeed found that the channel, which now has a leucine residue at the Q / R site, is no longer significantly affected by the toxin (Fig. 8 B) . To obtain f urther evidence we used our mutant GluR6-PK BP(Rp)L583Q, which tests the "reverse" situation in which the leucine has been converted into a glutamine. As expected, this mutant could now be blocked by PhT x (data not shown).
Transplantation of functional ion pores into KBPs
We have demonstrated that the ion channel domains of KBPs are functional in the sequence background of both the KA receptor GluR6 and the AMPA receptor GluR1 but not in their own (KBP) sequence background. This suggested that most likely communication between the ligand binding site and the ion channel domain is disrupted in homomeric KBPs. If this is indeed the case, a functional channel domain such as that of GluR1 or GluR6 when inserted into a KBP should not be able to rescue function but rather should produce nonfunctional chimeric receptors. To test this we engineered the appropriate "reverse" chimeras, transplanting the ion channel domains of GluR6 and GluR1 into KBP(Rp). These chimeras when expressed in Xenopus oocytes did not produce any measurable currents on activation with the glutamatergic agonists Glu, KA, or Dom, although the chimeric proteins were clearly synthesized and inserted into the plasma membrane (Fig. 4 B) . We also attempted to rescue function of the N-terminally elongated KBP construct GluR6N-KBP(Rp)C by transplanting the pore domain of GluR6 into this clone, creating the chimera GluR6-Rp-R6-Rp (Fig. 1, bottom bar  graph) . This construct was also nonfunctional, although it was expressed and transported to the plasma membrane (Fig. 4C) .
Thus, even with a highly functional ion channel domain such as that of GluR6(Q), these receptor subunits failed to translate ligand binding into channel opening, supporting our conclusion that the gating mechanism rather than the ion pore is dysfunctional in homomeric KBPs.
DISCUSSION N-terminal elongation does not rescue KBP function
N-terminal domains have been swapped between GluR6 and NMDAR1 GluR subunits without loss of function (Stern-Bach et al., 1994) . Because even a remotely related subunit such as NMDAR1 (only 34.1% sequence identity with GluR6) evidently can serve as the donor of an N-terminal domain, it was not unreasonable to expect that the much more closely related KBP(Rp) (40.0% sequence identity) might be functionally rescued by a grafted N-terminal domain from GluR6; however, the N-terminal transplant did not render KBP(Rp) functional. The failure to produce a functional chimera indicates that the short N-terminal domain in KBPs is not likely the reason for lack of channel function.
Transplanted KBP ion pores are functional
The overall distribution of hydrophobic domains in KBPs is similar to that of functional GluRs (Fig. 1) , and even the gene structure that has been elaborated for KBP(Gd) (Eshhar et al., Gregor et al., 1992 ) is quite similar. Furthermore, the topology that has been shown for KBP(Ca)␣ and KBP(Ca)␤ based on N-glycosylation studies (Wo and Oswald, 1994 ) is identical to that proposed for GluR1 , GluR3 (Bennett et al., 1995) , and NMDAR1 (Wood et al., 1995) . The obvious structural resemblance between KBPs and other GluRs suggested that domains from KBP subunits could potentially be exchanged for equivalent domains of functional GluRs, and vice versa. Indeed, when we inserted the hypothetical ion pore domains of KBPs in GluR1 or GluR6 we obtained functional chimeras, although maximal current amplitudes reached only 1-10% of the currents found in the parent clones. The domains transplanted consisted of the entire region between TMDs A and B (Fig. 2) rather than just the hydrophobic stretch that is thought to loop into the membrane to form the ion pore . This design was chosen because recent cysteine scanning mutagenesis data (Kuner et al., 1996) suggested that the sequences flanking the pore loop participate to some extent in establishing the structure of the pore.
Chimeras containing pores from KBPs had pharmacological characteristics and agonist affinities virtually indistinguishable from those of the ligand binding site donor subunit, demonstrating that the properties of the extracellular ligand binding site of GluRs are not dependent on the pore structure to which that site is connected. This conclusion is consistent with the work of Keinänen and colleagues, who reported construction of a functional soluble ligand binding site solely derived from the two extracellular halves of the ligand binding domain, without any pore structure in between (Kuusinen et al., 1995; Arvola and Keinänen, 1996) .
KBP ion pores have distinct properties
The properties of the pore domains of the five known KBPs tested as domain transplants in GluR6 are very similar. This is not unexpected given the high amino acid sequence homology of these regions (56 -76% among the five KBPs), and in particular the presence of a leucine residue in all five genes at a position that is homologous to the Q/R/N editing site in AMPA, KA, and NMDA receptors. All five pore domains have rectifying I-V values as might be predicted from the absence of an arginine residue at the Q/R/N editing site (Hume et al., 1991) , and they all are presumably permeable to calcium, although we verified this only for GluR6-PKBP(Ca)␣ and GluR6-PKBP(Xl). The KBP pore domains are not blocked by NMDA receptor channel blockers, such as magnesium or MK-801, but are inhibited by zinc, which at high concentrations (Ͼ100 M) does not discriminate ␣ and GluR6(Q590L) in N FR and calcium-free, magnesium-substituted N FR (MgR), and I-V of the mutant chimera GluR6-PKBP(Rp)L583Q. Note that lack of outward rectification is observed only in GluR6(Q590L) in MgR. At least three oocytes were measured for each chimera and gave identical curves. between NMDA and non-NMDA receptors (Westbrook and Mayer, 1987; Rassendren et al., 1990) . Interestingly, the KBP pore domains are not affected by the wasp toxin PhTx, other spider toxins, or their synthetic analogs, and we showed that this property is linked to the presence of a peculiar leucine residue at the Q/R/N site that is unique to KBPs. Thus, the properties of the KBP ion pore as reflected in the channel properties of the GluR6-KBP chimeras are distinct from those of AMPA, KA, and NMDA receptors, although they somewhat resemble properties of typical KA receptors.
KBPs are defective in gating
If all KBPs have functional agonist binding sites as has been shown previously (Henley, 1994) , and if the pores of KBPs in principle are capable of conducting currents as our experiments showed, why then are these subunits nonfunctional as ligandgated ion channels? Obviously, homomerically expressed KBP subunits fail to translate ligand binding into channel opening. Because ligand binding generally is assumed to cause a conformational change in the extracellular domain of the receptors (Mano et al., 1996; Laube et al., 1997) , which presumably represents the gating step required to open the ion channel, it may be concluded that homomerically expressed KBPs either fail to generate the appropriate conformational change or fail to communicate it to the pore. This conclusion is backed by our observation that the functional pore domains of GluR6 or GluR1, when inserted into KBP(Rp), failed to generate functional ion channels.
KBPs likely lack an essential subunit
It seems unlikely that some secondary modification of the receptor protein such as phosphorylation, which has been shown for KBP(Rp) (Ortega and Teichberg, 1990; Ibarra and Ortega, 1995) , or glycosylation is required to "switch on" the interrupted binding site-to-ion pore communication in KBPs. Such a mechanism most likely would have been detected in one of the various expression systems tried for the KBP clones, such as Xenopus oocytes, chinese hamster ovary cells, and human embryonic kidney cells (for review, see Henley, 1994) . Rather, it seems likely that an additional subunit may be required that interacts with the KBPs to reestablish the connection between ligand binding site and ion channel. This modulatory subunit may be either an accessory protein or another subunit of the GluR family. Among GluRs, several cases of homomerically nonfunctional subunits have been observed that are rendered functional only on coassembly with another subunit. Examples are the NR2 subunits of the NMDA receptor subfamily (Monyer et al., 1992) or the KA2 subunit of the KA receptor subfamily . Recently it was reported that KBP(Xl) formed functional ion channels of a peculiar, novel pharmacology on coexpression with the NMDAR1 subunit of Xenopus laevis. None of the two subunits was functional by itself, but on coexpression formed channels that ) . B, Absence of block by PhT x. K A (100 M) was applied for 50 -60 sec, followed by a brief wash and another application of 100 M K A followed within 2 sec by additional application of the open channel blocker PhT x (0.5 M). Note lack of block of two ion pore transplantation chimeras and mutant GluR6(Q590L), whereas GluR6(Q) is rapidly and efficiently blocked. Three to four oocytes were measured in each case and gave identical results.
reportedly were activated by specific agonists for all pharmacological subclasses of GluRs, AM PA, K A, and NMDA, and KBP(X l) was therefore dubbed "unitary" receptor . This report is in agreement with our finding that the pore of K BP(X l) is f unctional. Other K BPs, however, have not been examined in coexpression experiments with NMDAR1 subunits from the same species, and our own attempts to coexpress KBPs with the rat NMDAR1 subunit in Xenopus oocytes did not yield f unctional receptors other than typical homomeric NMDA receptors (C. Villmann and M. Hollmann, unpublished data). Thus, although it is possible that K BPs from other species might also form f unctional receptors with NMDAR1 subunits, there is currently no evidence for this. K BP(X l) differs from all other KBPs in binding both K A and AM PA with high affinity . Therefore, it is possible that this subunit plays a quite different role and indeed has unique properties not shared by any of the other K BPs.
GluRs are modular proteins
Our data support the view that GluRs are modular proteins with structural features derived from a number of different precursor proteins (Seeburg, 1993; Wo and Oswald, 1995) . In particular, the demonstration that pore regions can be transplanted between distantly related subunits without killing f unction strongly supports the hypothesis that GluRs indeed might have evolved from bacterial amino acid binding proteins by insertion of a pore domain in between the two ligand binding subdomains (O'Hara et al., 1993; Kuryatov et al., 1994; Stern-Bach et al., 1994) .
In summary, we conclude that K BPs in addition to harboring perfectly f unctional ligand binding sites also have intrinsically functional ion channel domains that display inward rectification, allow significant calcium permeability, and have distinct pharmacological properties. Our findings suggest that the elusive physiological role of K BPs may indeed be that of Glu-activated ion channels. We speculate that one or more additional subunits or an accessory protein may be required to twist the subunits in a heteromeric receptor complex just enough to enable the occupied ligand binding site to successf ully gate the ion channel. Furthermore, the chimera construction approach presented in this study should prove usef ul in analyzing the mechanism of channel gating in GluRs and defining the molecular pathway involved in signal transduction from the agonist binding site to the ion pore.
